At a glance
Foundational matrix experiments are supplemented here by a positive topical diabetic-ulcer trial, a small post-laser trial with null objective endpoints, and a recent preliminary eyebrow-serum conference report. These are distinct research questions.
Identity & scope
GHK-Cu is the copper complex of glycyl-histidyl-lysine. Copper-bound GHK, unbound GHK and a formulated product should be distinguished when interpreting experiments.
What the research shows
- Fibroblast and rat experiments support investigation of extracellular-matrix biology.
- Human topical studies report both favourable and null results, depending on population, formulation and outcome.
Critical interpretation
A matrix signal and a clinical outcome answer different questions
The early experiments identify a biological response under controlled exposure conditions. Their matrix measurements are useful for developing hypotheses, but more collagen is not a universal proxy for better healing. The diabetic-ulcer trial tested a particular gel alongside a structured care programme. Its favourable result belongs to that setting; it cannot be transferred to an oral or nasal format, or treated as a general rejuvenation result. [1] [2] [3]
Read the mixed human evidence by endpoint
The post-laser trial illustrates why a single success label loses information. Patients preferred the copper-peptide regimen, yet blinded and computer-based assessments did not show an objective advantage. Both results should remain visible. The newer eyebrow study is a positive but preliminary conference report with a small sample and a specific topical serum. Neither its cosmetic endpoints nor its short adverse-event observation settles long-term safety or the effectiveness of a different supplied formulation. Independent replication and chemically explicit test materials would make subsequent evidence more transferable. [4] [5]
Formulation is part of the scientific question
A topical gel, a post-procedure skin regimen and an eyebrow serum are different interventions. Reading them as interchangeable would erase differences in exposure, other ingredients and clinical context. A useful next study would specify its active material and vehicle and then connect that definition to the outcome measured. [3] [4] [5]
Limitations & uncertainties
- More collagen or extracellular matrix in an experimental system does not necessarily mean better clinical healing or appearance.
- The cited studies do not measure human oral or nasal bioavailability or validate catalogue formulations.
Open research questions
- Which independently replicated human endpoints, formulations and delivery systems are supported by sufficiently controlled research?
Selected papers & source records
Download bibliography1. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ (opens in a new tab)
Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP (1988). FEBS Letters. DOI: 10.1016/0014-5793(88)80509-X (opens in a new tab) · PMID 3169264
- Design & population
- Fibroblast culture experiment measuring collagen synthesis after GHK-Cu exposure.
- What the study found
- The authors reported stimulation of collagen synthesis.
- Limits on interpretation
- A cell-culture biochemical endpoint, without a human clinical outcome or validation of a retail formulation.
2. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds (opens in a new tab)
Maquart FX, Bellon G, Chaqour B, et al. (1993). Journal of Clinical Investigation. DOI: 10.1172/JCI116842 (opens in a new tab) · PMID 8227353
- Design & population
- Rat subcutaneous wound chambers with saline or GHK-Cu, followed by biochemical tissue analysis.
- What the study found
- Collagen, glycosaminoglycans and other matrix-related measurements increased; a control tripeptide had no significant effect.
- Limits on interpretation
- An artificial wound-chamber model does not establish human wound outcomes or rejuvenation.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
3. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper (opens in a new tab)
Mulder GD, Patt LM, Sanders L, et al. (1994). Wound Repair and Regeneration. DOI: 10.1046/j.1524-475X.1994.20406.x (opens in a new tab) · PMID 17147644
- Design & population
- Multicentre randomised evaluator-blinded vehicle-controlled study of a topical copper-peptide gel with standardised diabetic-ulcer care.
- What the study found
- The report describes greater plantar-ulcer area closure and fewer infections in the relevant treated comparison.
- Limits on interpretation
- A specific gel, wound type and co-intervention protocol. Abstract-level review does not resolve the full sample flow, subgroup structure or modern reporting-quality questions.
4. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin (opens in a new tab)
Miller TR, Wagner JD, Baack BR, Eisbach KJ (2006). Archives of Facial Plastic Surgery. DOI: 10.1001/archfaci.8.4.252 (opens in a new tab) · PMID 16847171
- Design & population
- Randomised post-laser topical-regimen comparison, 13 completers; objective and blinded assessments over 12 weeks.
- What the study found
- No significant between-group objective advantage in erythema resolution, wrinkles or skin quality. Patient satisfaction favoured GHK-Cu.
- Limits on interpretation
- Small study of whole topical regimens after a procedure, with subjective and objective outcomes giving different signals.
5. The efficacy of 2% copper peptide (GHK-Cu) serum for eyebrow hypotrichosis: a randomized, double-blind, vehicle-controlled, split-face comparative study (opens in a new tab)
Bo SL, Nararatwanchai T, Supornpun N, Poomarapan K, Thaploka S (2026). Procedia of Multidisciplinary Research (conference proceedings).
- Design & population
- Single-centre split-face serum comparison in 18 adults over 12 weeks, published as a conference-proceedings report.
- What the study found
- The authors report improved eyebrow hair count, diameter and photographic scores on the active-serum side.
- Limits on interpretation
- Small preliminary conference report; no independent replication or detailed copper-complex identity/exposure characterisation established. Eyebrow findings do not establish scalp or systemic outcomes.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
Search & review scope
Targeted primary literature searches and journal/PubMed checks of foundational matrix studies.. Checked 9 November 2026.
Selected foundational studies and contrasting human topical reports, including a 2026 preliminary conference-proceedings study.
The ulcer and laser reports were reviewed at abstract level; eyebrow methods/results were checked in full text. The laser publisher's View correction link was followed and led to the issue Highlights article (10.1001/archfaci.8.4.232), not a displayed substantive erratum. This is not comprehensive correction/retraction clearance.
Recorded search terms
- GHK-Cu 8227353 Maquart 1993
- site.pubmed.ncbi.nlm.nih.gov GHK Cu collagen fibroblasts 1988 3169264
- Stimulation of collagen synthesis in fibroblast cultures retracted
- GHK-Cu copper tripeptide CO2 laser resurfaced skin randomized 2006 PubMed
- Enhanced healing of ulcers in patients with diabetes by topical treatment glycyl 1994
- GHK-Cu eyebrow randomized 2026 trial
- Effects of topical copper correction 8.4.232
Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.
Cite this review
HeartPep. GHK-Cu: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/ghk-cu.
HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.
Buy from HeartPep.com
Laboratory research only. Not for human or veterinary use.